Bundamedik Tbk PT Cash Flow Reinvestment Rate
Bundamedik Tbk PT cash flow reinvestment rate. Bundamedik Tbk PT (BMHS) has a Cash Flow Reinvestment Rate of 0.58x as of December 2025, reinvesting Rp116.26 Billion (capex Rp116.26 Billion ) from operating cash flow of Rp199.64 Billion. See Bundamedik Tbk PT financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Bundamedik Tbk PT (2018–2025)
Cash flow reinvestment rate of Bundamedik Tbk PT from 2018 to 2025. Historical reinvestment intensity for Bundamedik Tbk PT across 8 annual periods. Explore cash flow to debt ratio of Bundamedik Tbk PT to assess how comfortably operating cash covers total debt obligations.
Bundamedik Tbk PT Cash Flow Reinvestment Rate by Year (2018–2025)
Bundamedik Tbk PT cash flow reinvestment rate by year from 2018 to 2025. Year-by-year capital reinvestment analysis for Bundamedik Tbk PT. For the full cash flow conversion analysis, see Bundamedik Tbk PT (BMHS) cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (IDR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.87x | Rp218.91 Billion | Rp250.62 Billion | Rp218.91 Billion | ▼ -93.8% |
| 2024 | 14.16x | Rp481.32 Billion | Rp33.98 Billion | Rp236.03 Billion | ▲ +72.8% |
| 2023 | 8.20x | Rp421.57 Billion | Rp51.44 Billion | Rp209.35 Billion | ▲ +163.1% |
| 2022 | 3.12x | Rp739.76 Billion | Rp237.47 Billion | Rp301.73 Billion | ▲ +336.2% |
| 2021 | 0.71x | Rp249.57 Billion | Rp349.44 Billion | Rp228.08 Billion | ▲ +91.2% |
| 2020 | 0.37x | Rp71.10 Billion | Rp190.36 Billion | Rp49.61 Billion | ▼ -60.2% |
| 2019 | 0.94x | Rp84.26 Billion | Rp89.72 Billion | Rp72.50 Billion | ▼ -73.7% |
| 2018 | 3.57x | Rp156.54 Billion | Rp43.79 Billion | Rp156.54 Billion | — |